INBX: Inhibrx Biosciences, Inc. Stock

by  •  • Comments Off on INBX: Inhibrx Biosciences, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 186.45
Enterprise Value ($M) 68.58
Book Value ($M) 94.44
Book Value / Share 6.52
Price / Book 1.97
NCAV ($M) 75.19
NCAV / Share 5.19
Price / NCAV 2.48

Profitability (mra)
Return on Invested Capital (ROIC) 8.57
Return on Assets (ROA) 61.05
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 5.08
Current Ratio 5.12

Balance Sheet (mrq) ($M)
Current Assets 223.39
Assets 242.64
Liabilities 148.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.20
Operating Income -331.45
Net Income 1,687.57

Cash Flow Statement (mra) ($M)
Cash From Operations -194.41
Cash from Investing -2.60
Cash from Financing 71.68

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-26 13D/A Lappe Mark 6.40 21.54
02-26 13D/A The Jon F. Kayyem and Paige Gates-Kayyem Family Trust 7.90
02-04 13G BlackRock, Inc. 5.70
11-14 13G Perceptive Advisors Llc 9.90 -24.39
06-07 13G Viking Global Investors Lp 12.30
06-03 13D Kayyem Jon Faiz 5.65
05-31 13G Sanofi 8.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-28 3,053 19,367 15.76
2025-05-27 21,454 84,135 25.50
2025-05-23 14,217 66,405 21.41

(click for more detail)

Similar Companies
IGMS – IGM Biosciences, Inc. IMUX – Immunic, Inc.
IMVT – Immunovant, Inc. INDV – Indivior PLC
INNV – InnovAge Holding Corp.


Financial data and stock pages provided by
Fintel.io